product summary
Loading...
company name :
OriGene
product type :
antibody
product name :
H.PYLORI Mouse Monoclonal Antibody [Clone ID: ULC3R]
catalog :
TA355304
quantity :
1 ml
price :
2546 USD
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
ULC3R
application :
immunohistochemistry
more info or order :
image
image 1 :

product information
SKU :
TA355304
Category :
Antibodies
Sub-Category :
Primary Antibodies
Name :
H.PYLORI Mouse Monoclonal Antibody [Clone ID: ULC3R]
Description :
H.PYLORI Mouse Monoclonal Antibody
Size :
1 ml
Price US :
2546 USD
Delivery Time US :
3 Weeks
Clonality :
Monoclonal
Clone Name :
ULC3R
Host :
Mouse
Isotype :
IgG1
Applications :
IHC
Reactivity :
Helicobacter pylori
more info or order :
company information

OriGene
9620 Medical Center Dr., Suite 200
Rockville, MD 20850
Rockville, MD 20850
custsupport@origene.com
https://www.origene.com1-888-267-4436
headquarters: USA
OriGene Technologies, Inc. is a gene centric life sciences company dedicated to support biomedical scientists in gene functions and drug discovery. OriGene’s novel product line includes the world’s largest collections of cDNA clones (TrueClone and TrueORF), shRNA (HuSH-29), purified human recombinant proteins, high quality TrueMAB™ monoclonal antibodies to human proteins, 100,000 highly validated human tissues, and qPCR arrays. OriGene also provides a broad range of antibody validation products including genome-wide tagged antigen standards and extensive IHC slides derived from our tissue collection. OriGene is a Luminex Certified Partner™ and offers multiplexed immunoassays and multiplexed assays for a broad range of biomarkers.
browse more products
- Human Herpesvirus 8 (HHV8) Mouse Monoclonal Antibody [Clone ID: 13B10]
- IL6 Mouse Monoclonal Antibody [Clone ID: 10C12] | TA355306
- IGKC Mouse Monoclonal Antibody [Clone ID: CH15] | TA355307
- Ki67 (MKI67) Mouse Monoclonal Antibody [Clone ID: MM1] | TA355308
- Lambda Light Chain Mouse Monoclonal Antibody [Clone ID: SHL53] | TA355309
questions and comments